Email
Print
Inflammatory Bowel Disease Market - Forecast(2024 - 2030)
Inflammatory Bowel Disease Market Overview
Inflammatory Bowel Disease Market Size is estimated to reach $26.3
billion by 2027 and is poised to grow at a CAGR of 5.9% over the
forecast period of 2022-2027. Inflammatory
bowel disease (IBD) is an umbrella term used to describe disorders that involve
chronic inflammation of the digestive tract. It includes ulcerative colitis, a
condition in which inflammation and soreness of the superficial lining of the
rectum and colon, and in Crohns disease affect any part of the gastrointestinal
tract. The cause of IBD is unknown, but it mostly occurred after weaken
immunity power. Some agent or combination of agents such as bacteria, viruses,
and antigens are considered as responsible to trigger the immune system, and
causing inflammation. The common symptoms of IBD are abdominal pain, weight
loss, persistent diarrhea, rectal bleeding, and fatigue. To treat such disease
medication with amino-salicylates, immunomodulators, antibiotics, corticosteroids,
and biologics are used. According to a Medscape article published in 2020, the
highest rate of IBD is assumed to be in developed countries. The incidence of
IBD is between 0.5-24.5 cases per 100,000 person-years for Crohns disease and
0.1-16 cases per 100,000 person-years for ulcerative colitis globally.
Such growing occurrence of Crohns disease and ulcerative colitis in developed countries, and growing consciousness across the world propel the growth of the Inflammatory Bowel Disease Industry. Also, the presence of key market players and rising research and developments support the growth of the Inflammatory Bowel Disease Market Size. For instance, in May 2022, Food and Drug Organization approved the new drug Zeposia for treating moderate to severe ulcerative colitis in adults. Such new products launched in the market, and expansion in key market players further fuel the growth of the Inflammatory Bowel Disease Industry over the forecast period 2022-2027.
Inflammatory Bowel Disease Market Report Coverage
The report: “Inflammatory Bowel Disease Market Forecast
(2022-2027)", by Industry ARC covers an in-depth analysis of the following
segments in the Inflammatory Bowel Disease Market.
Key Takeaways
- Geographically, North America held a dominant market share in the year 2021, owing to the increasing prevalence of Inflammatory Bowel Diseases, and developed healthcare facilities assist the growth of the Inflammatory Bowel Disease Market Size in this region.
- The rising consciousness among consumers propels the growth of the Inflammatory Bowel Disease Market Size in this region.
- The Inflammatory Bowel Disease Market is predicted to grow owing to the growing burden of Inflammatory Bowel Disease around the world and raising consciousness among consumers. However, the high price of treatment may limit market growth over the forecast period 2022-2027.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Inflammatory Bowel Disease Market Report.
Inflammatory Bowel Disease Market: Market Share (%) by region, 2021.
For More Details On this report - Request For Sample
Inflammatory Bowel Disease Market Segment Analysis- By Type
The Inflammatory Bowel Disease Market based on type can be further
segmented into Ulcerative Colitis and Crohns Disease. The Crohn’s segment held
a dominant market share in the year 2021. This is owing to the increasing
prevalence of Crohns disease and growing number of patients undergoing
treatment for Crohns disease around the world. The inflammatory symptoms of
Crohn disease can progress from mild to moderate to severe invasive
(fistulization) or stricturing disease. To treat this type of condition anti-TNF agents like
infliximab, adalimumab, golimumab and others are used. Growing research and
developments in healthcare sector and increasing
awareness about Inflammatory Bowel Disease around the world fuel market growth. For
instance, in May 2022, a tool was developed with help of artificial intelligence
to predict the postoperative recurrence of Crohns disease. Such rapid growth in
technology and growing investment in the healthcare sector drive the growth of
the Inflammatory Bowel Disease Market Share.
However, Ulcerative Colitis
is estimated to grow with the fastest CAGR rate of 6.2%
over the forecast period 2022-2027. As ulcerative colitis can affect any part
of the digestive tract and have a possibility to stand as a lifelong illness,
hence treatment for ulcerative colitis is in demand. To early diagnose this
type of disease various diagnostics methods like serologic markers, complete
blood cell count, comprehensive metabolic panel, inflammation markers, and
stool assay are getting demand in the market. As per Crohn’s & Colitis UK
in 2022 predict, 1 in every 123 people in the UK have either Crohns disease or
ulcerative colitis. This amounts to a total of nearly half a million people in
the UK living with IBD. Such increasing cases of IBD related diseases,
especially ulcerative colitis propels the growth of the Inflammatory
Bowel Disease Market share over the forecast period 2022-2027.
Inflammatory Bowel Disease Market Segment Analysis- By Route of Administration
Inflammatory Bowel Disease Market based on the route of
administration can be further segmented into Oral, and Injectables. The injectables
segment held a dominant market share in the year 2021. This is the result of
the increasing use of biologics for the treatment of ulcerative colitis and
Crohns disease. For instance, in February 2021, AbbiVie Inc, announced the FDA
approval of HUMIRA to treat moderate to severely active ulcerative colitis in pediatric
patients. Such a growing number of new products like amino-salicylates, immunomodulators,
antibiotics, corticosteroids, and biologics in the market and increasing demand
for biologics drive the growth of the Inflammatory Bowel Disease Market shares.
However, Oral is estimated to grow with the fastest CAGR rate of 5.7% over the forecast period 2022-2027. This is owing to the growing demand for oral drugs in the treatment of inflammatory bowel disease. Also, oral drug offer a better and more convenient option to control disease progression and improve quality of life. In May 2021, Ozanimod get FDA approval for relapsing forms of multiple sclerosis, in the United States for a second high-need medical condition, ulcerative colitis. Such growing developments in the treatment of inflammatory bowel disease fuel the growth of the Inflammatory Bowel Disease Market Share over the forecast period 2022-2027.
Inflammatory Bowel Disease Market Segment Analysis- By Geography
The Inflammatory Bowel Disease Market based on Geography can be
further segmented into North America, Europe, Asia-Pacific, South America, and
the Rest of the World. North America held a dominant market share of 38% in the
year 2021. This is the result of the increasing number of cases of inflammatory
bowel disease in this region. As per Medscape in 2020, North America reported
319 cases per 100,000 people. As per Crohn’s & Colitis Foundation, about 70,000
new cases of IBD are diagnosed in the United States each year. Such a growing prevalence
of IBD cases and the presence of developed healthcare facilities in this region
drive the growth of the Inflammatory Bowel Disease Market Size.
Furthermore, Asia-Pacific is estimated to grow with the fastest CAGR rate of 6.5% over the forecast period 2022-2022. This is owing to the increasing awareness about inflammatory bowel disease in this region. Increasing healthcare spending and better diagnostics techniques available in the region improve the diagnosis of inflammatory bowel disease. According to the research paper published in BMC Gastroenterology in 2021, compared to 2020 cases of inflammatory bowel disease is expected to raise by 2.5 fold in Iran with 69 thousand cases, 2.3 fold increment in North Africa and the Middle East with 220 thousand cases. Also, quadrupling prevalence in India with 2.2 million cases, 1.5 fold increases in East-Asia with 4.5 million cases. Such increasing prevalence of IBD and growing demand for diagnostics fuel the growth of the Inflammatory Bowel Disease Market Size in this region over the forecast period 2022-2027.
Inflammatory Bowel Disease Market Drivers:
Increasing Rate of Inflammatory Disease Drive the Market Growth.
The increasing prevalence of inflammatory
disease and growing number of patients undertaking treatment for inflammatory
bowel disease drive the inflammatory bowel disease industry. Inflammatory bowel
disease is tiggered with genetic predisposition, environmental triggers, and
immune system disturbance. The majority of cases show family history is most
prevalent cause of inflammatory bowel disease. The majority of monogenic IBD
cases occur in children diagnosed under 6 years of age. Recent advanced in
technology like next generation sequencing make it easier to diagnose such rear
genetic disease. According to the American Gastroenterological Association
(AGA) report published in 2020, the forecasted IBD prevalence in 2030 was 981
per 100,000 including 493 per 100,000 with Crohns Disease and 436 per 100,000
with Ulcerative Colitis. Such increasing cases of inflammatory bowel disease
fuel the growth of the Inflammatory Bowel Disease Industry over the forecast
period 2022-2027.
Strong Portfolio of Pipeline Molecules to Increase Product Launches Drives the Market Growth.
With rising
prevalence of inflammatory bowel disease and increasing awareness in about such
rear disease in people around the world create strong demand for early
diagnosis techniques and medication are the major factors responsible for
market growth. According to ClinicalTrials.gov more than 145 studies are open
for treatment of Crohns disease and ulcerative colitis, and majority of the
molecules are in the final phase of the clinical trials. In March 2022, Tiziana
announced the initiation of phase 1b clinical trial in Crohns disease patients
to evaluate oral capsules of Foralumab, a fully human Anti-CD3 monoclonal antibody.
According to ClinicalTrials.gov total of 4216 participants are registered under
patient registry for clinical trials of inflammatory bowel disease. Such
raising clinical trials and number of molecules are in the final phase
available new drugs such as amino-salicylates, immunomodulators, antibiotics, corticosteroids,
and biologics for
treatment of IBD. Such increasing clinical trials and approvals for new drug
fuels the growth of the Inflammatory Bowel Disease Industry over the forecast
period 2022-2027.
Inflammatory Bowel Disease Market Challenges:
High Treatment Cost is Hampering the Market Growth.
In developing countries, there is a lack of awareness about
inflammatory bowel disease and a lack of proper diagnostic techniques which
reduce the number of patients undergoing treatment. The price of drugs like amino-salicylates,
immunomodulators, antibiotics, corticosteroids, and biologics are high in low
and middle-income countries. Also, low income and high burden of healthcare
expenditure limits access to the treatment. As per the world Bank Report
published in June 2022 about ‘Global Economic Prospect’ the rising risk of
stagflation with potentially harmful for middle and low-income countries.
According to the World Bank the global growth is expected to slump from 5.7
percent in 2021 to 2.9 percent in 2022. As per World Health Organisation (WHO),
in low and middle-income countries out-of-pocket spending was the main source
of health expenditure (44%). Owing to such conditions most of people are away
from good healthcare facilities and such factors may hamper market growth over
the forecast period 2022-2027.
Inflammatory Bowel Disease Market Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Inflammatory Bowel Disease Market. The top 10 companies in the Inflammatory Bowel Disease Market are:
- ABBOTT LABORATORIES
- Amgen Inc.
- ASTRAZENECA PLC
- ELI-LILLY
- INDEX PHARMACEUTICALS HOLDINGS AB
- GLAXOSIMITHKLINE PLC
- JOHNSON & JOHNSON
- Merck & Co. Inc.
- Pfizer Inc.
- SANOFI S.A
Recent Developments
- In April 2022, GlaxoSimithKline PLC, announced agreement to acquire Sierra Oncology, a California-based, late-stage biopharmaceutical company focused on targeted therapies for the treatment of rare forms of cancer for $ 1.9 billion.
- In March 2021, In order to gain access to a preclinical programme that has the potential to support tissue repair and regeneration, Amgen purchased the privately held Rodeo Therapeutics company. Investors in the Rodeo earned an initial payout of $55 million plus potentially to $666 million in subsequent milestone payments. The deal has previously been accepted by the board of directors and shareholders of the Seattle-based company Rodeo. The smaller company is creating treatments that work to impede an enzyme called 15-prostaglandin dehydrogenase, or 15-PGDH, which is responsible for the body's repair processes.
- In January 2020, Brazikumab, an interleukin 23 (IL-23) inhibitor currently being developed for inflammatory bowel disease (IBD), will have its global rights acquired by AstraZeneca from Allergan. Allergan and AstraZeneca will end their current license agreement, and AstraZeneca will receive full ownership of brazikumab.
Relevant Titles
Report Code:
HCR 0372
Report Code: HCR 0320
Report Code: HCR 1211
For more Lifesciences and Healthcare Market reports, please click here
Table 1: Inflammatory Bowel Disease Market Overview 2023-2030
Table 2: Inflammatory Bowel Disease Market Leader Analysis 2023-2030 (US$)
Table 3: Inflammatory Bowel Disease Market Product Analysis 2023-2030 (US$)
Table 4: Inflammatory Bowel Disease Market End User Analysis 2023-2030 (US$)
Table 5: Inflammatory Bowel Disease Market Patent Analysis 2013-2023* (US$)
Table 6: Inflammatory Bowel Disease Market Financial Analysis 2023-2030 (US$)
Table 7: Inflammatory Bowel Disease Market Driver Analysis 2023-2030 (US$)
Table 8: Inflammatory Bowel Disease Market Challenges Analysis 2023-2030 (US$)
Table 9: Inflammatory Bowel Disease Market Constraint Analysis 2023-2030 (US$)
Table 10: Inflammatory Bowel Disease Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Inflammatory Bowel Disease Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Inflammatory Bowel Disease Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Inflammatory Bowel Disease Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Inflammatory Bowel Disease Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Inflammatory Bowel Disease Market Value Chain Analysis 2023-2030 (US$)
Table 16: Inflammatory Bowel Disease Market Pricing Analysis 2023-2030 (US$)
Table 17: Inflammatory Bowel Disease Market Opportunities Analysis 2023-2030 (US$)
Table 18: Inflammatory Bowel Disease Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Inflammatory Bowel Disease Market Supplier Analysis 2023-2030 (US$)
Table 20: Inflammatory Bowel Disease Market Distributor Analysis 2023-2030 (US$)
Table 21: Inflammatory Bowel Disease Market Trend Analysis 2023-2030 (US$)
Table 22: Inflammatory Bowel Disease Market Size 2023 (US$)
Table 23: Inflammatory Bowel Disease Market Forecast Analysis 2023-2030 (US$)
Table 24: Inflammatory Bowel Disease Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 26: Inflammatory Bowel Disease Market By Product, Revenue & Volume, By Aminosalicylates, 2023-2030 ($)
Table 27: Inflammatory Bowel Disease Market By Product, Revenue & Volume, By Antibiotics, 2023-2030 ($)
Table 28: Inflammatory Bowel Disease Market By Product, Revenue & Volume, By Corticosteroids, 2023-2030 ($)
Table 29: Inflammatory Bowel Disease Market By Product, Revenue & Volume, By Biologic therapies (biological drugs), 2023-2030 ($)
Table 30: Inflammatory Bowel Disease Market By Product, Revenue & Volume, By Immunomodulators, 2023-2030 ($)
Table 31: Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 32: Inflammatory Bowel Disease Market By Disease Condition, Revenue & Volume, By Crohns disease, 2023-2030 ($)
Table 33: Inflammatory Bowel Disease Market By Disease Condition, Revenue & Volume, By Ulcerative colitis, 2023-2030 ($)
Table 34: Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 35: Inflammatory Bowel Disease Market By Application, Revenue & Volume, By Therapeutic, 2023-2030 ($)
Table 36: Inflammatory Bowel Disease Market By Application, Revenue & Volume, By Diagnostics, 2023-2030 ($)
Table 37: North America Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 38: North America Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 39: North America Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 40: South america Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 41: South america Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 42: South america Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 43: Europe Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 44: Europe Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 45: Europe Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 46: APAC Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 47: APAC Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 48: APAC Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 49: Middle East & Africa Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 50: Middle East & Africa Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 51: Middle East & Africa Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 52: Russia Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 53: Russia Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 54: Russia Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 55: Israel Inflammatory Bowel Disease Market, Revenue & Volume, By Product, 2023-2030 ($)
Table 56: Israel Inflammatory Bowel Disease Market, Revenue & Volume, By Disease Condition, 2023-2030 ($)
Table 57: Israel Inflammatory Bowel Disease Market, Revenue & Volume, By Application, 2023-2030 ($)
Table 58: Top Companies 2023 (US$)Inflammatory Bowel Disease Market, Revenue & Volume
Table 59: Product Launch 2023-2030Inflammatory Bowel Disease Market, Revenue & Volume
Table 60: Mergers & Acquistions 2023-2030Inflammatory Bowel Disease Market, Revenue & Volume
List of Figures:
Figure 1: Overview of Inflammatory Bowel Disease Market 2023-2030
Figure 2: Market Share Analysis for Inflammatory Bowel Disease Market 2023 (US$)
Figure 3: Product Comparison in Inflammatory Bowel Disease Market 2023-2030 (US$)
Figure 4: End User Profile for Inflammatory Bowel Disease Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Inflammatory Bowel Disease Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Inflammatory Bowel Disease Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Inflammatory Bowel Disease Market 2023-2030
Figure 8: Ecosystem Analysis in Inflammatory Bowel Disease Market 2023
Figure 9: Average Selling Price in Inflammatory Bowel Disease Market 2023-2030
Figure 10: Top Opportunites in Inflammatory Bowel Disease Market 2023-2030
Figure 11: Market Life Cycle Analysis in Inflammatory Bowel Disease Market
Figure 12: GlobalBy ProductInflammatory Bowel Disease Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy Disease ConditionInflammatory Bowel Disease Market Revenue, 2023-2030 ($)
Figure 14: GlobalBy ApplicationInflammatory Bowel Disease Market Revenue, 2023-2030 ($)
Figure 15: Global Inflammatory Bowel Disease Market - By Geography
Figure 16: Global Inflammatory Bowel Disease Market Value & Volume, By Geography, 2023-2030 ($)
Figure 17: Global Inflammatory Bowel Disease Market CAGR, By Geography, 2023-2030 (%)
Figure 18: North America Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 19: US Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 20: US GDP and Population, 2023-2030 ($)
Figure 21: US GDP – Composition of 2023, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2023-2030 ($)
Figure 23: Canada Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 24: Canada GDP and Population, 2023-2030 ($)
Figure 25: Canada GDP – Composition of 2023, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 27: Mexico Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 28: Mexico GDP and Population, 2023-2030 ($)
Figure 29: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 31: South America Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 33: Brazil GDP and Population, 2023-2030 ($)
Figure 34: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 36: Venezuela Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 37: Venezuela GDP and Population, 2023-2030 ($)
Figure 38: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 40: Argentina Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 41: Argentina GDP and Population, 2023-2030 ($)
Figure 42: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 44: Ecuador Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 45: Ecuador GDP and Population, 2023-2030 ($)
Figure 46: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 48: Peru Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 49: Peru GDP and Population, 2023-2030 ($)
Figure 50: Peru GDP – Composition of 2023, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 52: Colombia Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 53: Colombia GDP and Population, 2023-2030 ($)
Figure 54: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 56: Costa Rica Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 57: Costa Rica GDP and Population, 2023-2030 ($)
Figure 58: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 60: Europe Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 61: U.K Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 62: U.K GDP and Population, 2023-2030 ($)
Figure 63: U.K GDP – Composition of 2023, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 65: Germany Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 66: Germany GDP and Population, 2023-2030 ($)
Figure 67: Germany GDP – Composition of 2023, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 69: Italy Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 70: Italy GDP and Population, 2023-2030 ($)
Figure 71: Italy GDP – Composition of 2023, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 73: France Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 74: France GDP and Population, 2023-2030 ($)
Figure 75: France GDP – Composition of 2023, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2023-2030 ($)
Figure 77: Netherlands Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 78: Netherlands GDP and Population, 2023-2030 ($)
Figure 79: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 81: Belgium Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 82: Belgium GDP and Population, 2023-2030 ($)
Figure 83: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 85: Spain Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 86: Spain GDP and Population, 2023-2030 ($)
Figure 87: Spain GDP – Composition of 2023, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 89: Denmark Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 90: Denmark GDP and Population, 2023-2030 ($)
Figure 91: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 93: APAC Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 94: China Inflammatory Bowel Disease Market Value & Volume, 2023-2030
Figure 95: China GDP and Population, 2023-2030 ($)
Figure 96: China GDP – Composition of 2023, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2023-2030 ($)Inflammatory Bowel Disease Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 98: Australia Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 99: Australia GDP and Population, 2023-2030 ($)
Figure 100: Australia GDP – Composition of 2023, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 102: South Korea Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 103: South Korea GDP and Population, 2023-2030 ($)
Figure 104: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 106: India Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 107: India GDP and Population, 2023-2030 ($)
Figure 108: India GDP – Composition of 2023, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2023-2030 ($)
Figure 110: Taiwan Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 111: Taiwan GDP and Population, 2023-2030 ($)
Figure 112: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 114: Malaysia Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 115: Malaysia GDP and Population, 2023-2030 ($)
Figure 116: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 118: Hong Kong Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 119: Hong Kong GDP and Population, 2023-2030 ($)
Figure 120: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 122: Middle East & Africa Inflammatory Bowel Disease Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 123: Russia Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 124: Russia GDP and Population, 2023-2030 ($)
Figure 125: Russia GDP – Composition of 2023, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 127: Israel Inflammatory Bowel Disease Market Value & Volume, 2023-2030 ($)
Figure 128: Israel GDP and Population, 2023-2030 ($)
Figure 129: Israel GDP – Composition of 2023, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 131: Entropy Share, By Strategies, 2023-2030* (%)Inflammatory Bowel Disease Market
Figure 132: Developments, 2023-2030*Inflammatory Bowel Disease Market
Figure 133: Company 1 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 134: Company 1 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 135: Company 1 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 136: Company 2 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 137: Company 2 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 138: Company 2 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 139: Company 3 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 140: Company 3 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 141: Company 3 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 142: Company 4 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 143: Company 4 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 144: Company 4 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 145: Company 5 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 146: Company 5 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 147: Company 5 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 148: Company 6 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 149: Company 6 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 150: Company 6 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 151: Company 7 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 152: Company 7 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 153: Company 7 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 154: Company 8 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 155: Company 8 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 156: Company 8 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 157: Company 9 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 158: Company 9 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 159: Company 9 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 160: Company 10 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 161: Company 10 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 162: Company 10 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 163: Company 11 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 164: Company 11 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 165: Company 11 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 166: Company 12 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 167: Company 12 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 168: Company 12 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 169: Company 13 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 170: Company 13 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 171: Company 13 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 172: Company 14 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 173: Company 14 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 174: Company 14 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)
Figure 175: Company 15 Inflammatory Bowel Disease Market Net Revenue, By Years, 2023-2030* ($)
Figure 176: Company 15 Inflammatory Bowel Disease Market Net Revenue Share, By Business segments, 2023 (%)
Figure 177: Company 15 Inflammatory Bowel Disease Market Net Sales Share, By Geography, 2023 (%)